232 related articles for article (PubMed ID: 24493389)
21. Routine blood investigations have limited utility in surveillance of aggressive lymphoma in asymptomatic patients in complete remission.
Hawkes EA; Loh Z; Estacio O; Chong G; Ha FJ; Gilbertson M; Grigg A
Br J Cancer; 2018 Aug; 119(5):546-550. PubMed ID: 30033446
[TBL] [Abstract][Full Text] [Related]
22. [Therapy in Hodgkin disease and non-Hodgkin lymphomas].
Sréter L
Orv Hetil; 2009 Apr; 150(14):651-5. PubMed ID: 19318337
[TBL] [Abstract][Full Text] [Related]
23. 18F-FDG-PET/CT in the surveillance of patients with lymphoma: detection of asymptomatic recurrences.
García Vicente AM; Bellón Guardia M; Soriano Castrejón A; Calle Primo C; Cordero García JM; Palomar Muñoz A; Pilkington Woll JP; Talavera Rubio MP; Hernández Ruiz B
Rev Esp Med Nucl Imagen Mol; 2012; 31(1):22-7. PubMed ID: 21742419
[TBL] [Abstract][Full Text] [Related]
24. Detection of relapse in non-Hodgkin's lymphoma: role of routine follow-up studies.
Elis A; Blickstein D; Klein O; Eliav-Ronen R; Manor Y; Lishner M
Am J Hematol; 2002 Jan; 69(1):41-4. PubMed ID: 11835330
[TBL] [Abstract][Full Text] [Related]
25. Surveillance imaging of Hodgkin lymphoma patients in first remission: a clinical and economic analysis.
Lee AI; Zuckerman DS; Van den Abbeele AD; Aquino SL; Crowley D; Toomey C; Lacasce AS; Feng Y; Neuberg DS; Hochberg EP
Cancer; 2010 Aug; 116(16):3835-42. PubMed ID: 20564135
[TBL] [Abstract][Full Text] [Related]
26. Comparison of 2 Carmustine-Containing Regimens in the Rituximab Era: Excellent Outcomes Even in Poor-Risk Patients.
Caimi PF; William BM; Silva Rondon CH; Fu P; Cooper BW; Campagnaro EL; Gerson SL; Reese-Koc J; Fox R; Creger RJ; de Lima M; Lazarus HM
Biol Blood Marrow Transplant; 2015 Nov; 21(11):1926-31. PubMed ID: 26087475
[TBL] [Abstract][Full Text] [Related]
27. Relapse patterns of localized non-Hodgkin's lymphoma of the head and neck after clinical remission: results of a strict follow-up procedure.
Nakamura K; Sasaki M; Kunitake N; Kimura M; Watanabe T; Sasaki T; Terashima H; Kuwabara Y; Sakai S; Masuda K
Int J Clin Oncol; 2001 Dec; 6(6):302-5. PubMed ID: 11828950
[TBL] [Abstract][Full Text] [Related]
28. No survival benefit associated with routine surveillance imaging for Hodgkin lymphoma in first remission: a Danish-Swedish population-based observational study.
Jakobsen LH; Hutchings M; de Nully Brown P; Linderoth J; Mylam KJ; Molin D; Johnsen HE; Bøgsted M; Jerkeman M; El-Galaly TC
Br J Haematol; 2016 Apr; 173(2):236-44. PubMed ID: 26846879
[TBL] [Abstract][Full Text] [Related]
29. Role of Surveillance Imaging in Patients With Peripheral T-Cell Lymphoma.
Tang T; Chen Z; Praditsuktavorn P; Khoo LP; Ruan J; Lim ST; Tan D; Phipps C; Lee YS; Goh YT; Hwang W; Tao M; Quek R; Farid M; Furman RR; Leonard JP; Martin P
Clin Lymphoma Myeloma Leuk; 2016 Mar; 16(3):117-21. PubMed ID: 26796979
[TBL] [Abstract][Full Text] [Related]
30. The role of bone marrow biopsy and FDG-PET/CT in identifying bone marrow infiltration in the initial diagnosis of high grade non-Hodgkin B-cell lymphoma and Hodgkin lymphoma. Accuracy in a multicenter series of 372 patients.
Chen-Liang TH; Martin-Santos T; Jerez A; Senent L; Orero MT; Remigia MJ; Muiña B; Romera M; Fernandez-Muñoz H; Raya JM; Fernandez-Gonzalez M; Lancharro A; Villegas C; Carlos Herrera J; Frutos L; Luis Navarro J; Uña J; Igua C; Sanchez-Vaño R; Cozar Mdel P; Contreras J; Sanchez-Blanco JJ; Perez-Ceballos E; Ortuño FJ
Am J Hematol; 2015 Aug; 90(8):686-90. PubMed ID: 25925613
[TBL] [Abstract][Full Text] [Related]
31. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
32. Relapsed non-Hodgkin's lymphoma: detection and treatment.
Shioyama Y; Nakamura K; Kunitake N; Kimura M; Terashima H; Masuda K
Radiat Med; 2000; 18(6):369-75. PubMed ID: 11153690
[TBL] [Abstract][Full Text] [Related]
33. Contribution of involved-field radiotherapy to survival in patients with relapsed or refractory Hodgkin lymphoma undergoing autologous stem cell transplantation.
Eroglu C; Kaynar L; Orhan O; Keklik M; Sahin C; Yildiz OG; Mentes S; Kurnaz F; Aslan D; Sivgin S; Soyuer S; Eser B; Cetin M; Unal A
Am J Clin Oncol; 2015 Feb; 38(1):68-73. PubMed ID: 23563207
[TBL] [Abstract][Full Text] [Related]
34. Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma--results of the UK HD3 relapse treatment strategy.
Shankar A; Hayward J; Kirkwood A; McCarthy K; Hewitt M; Morland B; Daw S
Br J Haematol; 2014 May; 165(4):534-44. PubMed ID: 24754633
[TBL] [Abstract][Full Text] [Related]
35. Clinical and misdiagnosed analysis of primary pulmonary lymphoma: a retrospective study.
Yao D; Zhang L; Wu PL; Gu XL; Chen YF; Wang LX; Huang XY
BMC Cancer; 2018 Mar; 18(1):281. PubMed ID: 29530011
[TBL] [Abstract][Full Text] [Related]
36. Separate diagnoses of Hodgkin lymphoma and non-Hodgkin lymphoma in an individual patient might not signify a common clonal origin.
Ganzel C; Pogrebijsky G; Krichevsky S; Neuman T; Yehuda DB
Exp Hematol; 2012 Sep; 40(9):698-704.e2. PubMed ID: 22659385
[TBL] [Abstract][Full Text] [Related]
37. Role of 18FDG-PET/CT in detecting relapse during follow-up of patients with Hodgkin's lymphoma.
Crocchiolo R; Fallanca F; Giovacchini G; Ferreri AJ; Assanelli A; Verona C; Pescarollo A; Bregni M; Ponzoni M; Gianolli L; Fazio F; Ciceri F
Ann Hematol; 2009 Dec; 88(12):1229-36. PubMed ID: 19468730
[TBL] [Abstract][Full Text] [Related]
38. Late Relapse of Classical Hodgkin Lymphoma: An Analysis of the German Hodgkin Study Group HD7 to HD12 Trials.
Bröckelmann PJ; Goergen H; Kohnhorst C; von Tresckow B; Moccia A; Markova J; Meissner J; Kerkhoff A; Ludwig WD; Fuchs M; Borchmann P; Engert A
J Clin Oncol; 2017 May; 35(13):1444-1450. PubMed ID: 28240973
[TBL] [Abstract][Full Text] [Related]
39. Relapsed hodgkin lymphoma in older patients: a comprehensive analysis from the German hodgkin study group.
Böll B; Goergen H; Arndt N; Meissner J; Krause SW; Schnell R; von Tresckow B; Eichenauer DA; Sasse S; Fuchs M; Behringer K; Klimm BC; Naumann R; Diehl V; Engert A; Borchmann P
J Clin Oncol; 2013 Dec; 31(35):4431-7. PubMed ID: 24190119
[TBL] [Abstract][Full Text] [Related]
40. Non-Hodgkin's lymphoma of the paranasal sinuses: clinical and pathological features, and response to combined-modality therapy.
Hausdorff J; Davis E; Long G; Hoppe R; van der Pas M; Lassman C; Kamel O; Jacobs C
Cancer J Sci Am; 1997; 3(5):303-11. PubMed ID: 9327155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
